Slingshot Insights | Mrus Overview

MRUS Overview

Upcoming Projects (MRUS)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (MRUS)

Discussing the updated ASCO data in r/m HSNCC for Petosemtamab and Ficerafusp Alfa
Tickers: MRUS, BCAX, MRK
Executed On: Jun 04, 2025 at 01:30 PM EDT
A Second look at the potential of Merus’ Petosemtamab (MCLA-158) in combination with pembrolizumab as a first line treatment option for recurrent/metastatic head and neck squamous cell carcinoma and the Phase 2 data presented at ASCO.
Ticker: MRUS
Executed On: Jun 10, 2024 at 02:30 PM EDT
A look at the potential of Merus’ Petosemtamab (MCLA-158) in combination with pembrolizumab as a first line treatment option for recurrent/metastatic head and neck squamous cell carcinoma and the Phase 2 data presented at ASCO.
Ticker: MRUS
Executed On: Jun 04, 2024 at 04:30 PM EDT
Discussing the current use of Kyzatrex (testosterone undecanoate), an oral testosterone treatment from Marinus Pharmaceuticals.
Ticker: MRUS
Executed On: Dec 20, 2023 at 12:30 PM EST
A Second Look: Examining the potential of Merus' bispecific antibody, petosemtamab, in HNSCC with a focus on the data from the Phase 1/2 trial presented AACR 2023
Ticker: MRUS
Executed On: May 03, 2023 at 02:00 PM EDT
Examining the potential of Merus' bispecific antibody, petosemtamab, in HNSCC with a focus on the data from the Phase 1/2 trial presented AACR 2023
Ticker: MRUS
Executed On: May 02, 2023 at 09:30 AM EDT

Upcoming & Overdue Catalysts (MRUS)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (MRUS)

Don’t see a strategic initiative related to the company you care about? Create your own!